Literature DB >> 23604333

The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism.

Nadine Petrovsky1, Ulrich Ettinger, Henrik Kessler, Rainald Mössner, Steffen Wolfsgruber, Norbert Dahmen, Wolfgang Maier, Michael Wagner, Boris B Quednow.   

Abstract

RATIONALE: Prepulse inhibition (PPI) of the acoustic startle response, a measure of sensorimotor gating, can be enhanced by nicotine. Moreover, the TT genotype of the nicotinic acetylcholine receptor (nAChR) α3-subunit (CHRNA3) rs1051730 polymorphism has previously been associated with diminished PPI and nicotine dependence.
OBJECTIVES: We tested whether this CHRNA3 polymorphism also modulates the nicotine-induced enhancement of PPI.
METHODS: We assessed the effect of nicotine on PPI, startle reactivity, and habituation in 52 healthy nonsmoking volunteers genotyped for CHRNA3 rs1051730 in a double-blind, placebo-controlled, counterbalanced, within-subjects design. Additionally, cotinine plasma levels were measured.
RESULTS: Nicotine significantly enhanced PPI in TT homozygotes only and tended to worsen PPI in TC and CC carriers. Additionally, nicotine significantly reduced startle habituation.
CONCLUSIONS: The present findings imply that the effect of nicotine on sensorimotor gating is modulated by nAChR α3-subunits. Thus, genetic variation in nicotinic receptor genes might be an important connecting link between early attentional processes and smoking behavior.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604333     DOI: 10.1007/s00213-013-3081-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

Review 1.  Nicotine use in schizophrenia: the self medication hypotheses.

Authors:  Veena Kumari; Peggy Postma
Journal:  Neurosci Biobehav Rev       Date:  2005       Impact factor: 8.989

2.  Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Authors:  L Elliot Hong; Gunvant K Thaker; Robert P McMahon; Ann Summerfelt; Jill Rachbeisel; Rebecca L Fuller; Ikwunga Wonodi; Robert W Buchanan; Carol Myers; Stephen J Heishman; Jeff Yang; Adrienne Nye
Journal:  Arch Gen Psychiatry       Date:  2011-08-01

3.  Transdermal nicotine effects on attention.

Authors:  E D Levin; C K Conners; D Silva; S C Hinton; W H Meck; J March; J E Rose
Journal:  Psychopharmacology (Berl)       Date:  1998-11       Impact factor: 4.530

4.  CHRNA3 rs1051730 genotype and short-term smoking cessation.

Authors:  Marcus R Munafò; Elaine C Johnstone; Donna Walther; George R Uhl; Michael F G Murphy; Paul Aveyard
Journal:  Nicotine Tob Res       Date:  2011-06-20       Impact factor: 4.244

5.  Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers.

Authors:  V Kumari; P A Cotter; S A Checkley; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1997-08       Impact factor: 4.530

6.  Attenuation of the prepulse inhibition of the acoustic startle response within and between sessions.

Authors:  Boris B Quednow; Kai-Uwe Kühn; Katrin Beckmann; Jens Westheide; Wolfgang Maier; Michael Wagner
Journal:  Biol Psychol       Date:  2005-07-12       Impact factor: 3.251

Review 7.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

8.  A liquid chromatography-mass spectrometry method for nicotine and cotinine; utility in screening tobacco exposure in patients taking amiodarone.

Authors:  Raniah Q Gabr; Marwa E Elsherbiny; Vishwa Somayaji; P Timothy Pollak; Dion R Brocks
Journal:  Biomed Chromatogr       Date:  2011-02-10       Impact factor: 1.902

9.  Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.

Authors:  D V Poltavski; T Petros
Journal:  Physiol Behav       Date:  2006-02-07

10.  Effect of nicotine, lobeline, and mecamylamine on sensory gating in the rat.

Authors:  P Curzon; D J Kim; M W Decker
Journal:  Pharmacol Biochem Behav       Date:  1994-12       Impact factor: 3.533

View more
  7 in total

1.  Effects of nicotine on response inhibition and interference control.

Authors:  Ulrich Ettinger; Eliana Faiola; Anna-Maria Kasparbauer; Nadine Petrovsky; Raymond C K Chan; Roman Liepelt; Veena Kumari
Journal:  Psychopharmacology (Berl)       Date:  2017-02-01       Impact factor: 4.530

Review 2.  Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective.

Authors:  Boris B Quednow; Magdalena M Brzózka; Moritz J Rossner
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

3.  α3* Nicotinic Acetylcholine Receptors in the Habenula-Interpeduncular Nucleus Circuit Regulate Nicotine Intake.

Authors:  Karim S Elayouby; Masago Ishikawa; Angeline J Dukes; Alexander C W Smith; Qun Lu; Christie D Fowler; Paul J Kenny
Journal:  J Neurosci       Date:  2020-12-30       Impact factor: 6.167

4.  Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.

Authors:  Paulo Roberto Xavier Tomaz; Juliana Rocha Santos; Jaqueline Scholz; Tânia Ogawa Abe; Patrícia Viviane Gaya; André Brooking Negrão; José Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Júnior Lima Santos
Journal:  BMC Med Genet       Date:  2018-04-05       Impact factor: 2.103

5.  The Psychiatric Risk Gene Transcription Factor 4 (TCF4) Regulates Neurodevelopmental Pathways Associated With Schizophrenia, Autism, and Intellectual Disability.

Authors:  Marc P Forrest; Matthew J Hill; David H Kavanagh; Katherine E Tansey; Adrian J Waite; Derek J Blake
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

6.  Genetic Determinants of Gating Functions: Do We Get Closer to Understanding Schizophrenia Etiopathogenesis?

Authors:  Rastislav Rovný; Dominika Besterciová; Igor Riečanský
Journal:  Front Psychiatry       Date:  2020-11-25       Impact factor: 4.157

7.  Does chronic nicotine consumption influence visual backward masking in schizophrenia and schizotypy?

Authors:  Albulena Shaqiri; Julie Willemin; Guillaume Sierro; Maya Roinishvili; Luisa Iannantuoni; Linda Rürup; Eka Chkonia; Michael H Herzog; Christine Mohr
Journal:  Schizophr Res Cogn       Date:  2015-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.